{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:54:36Z","timestamp":1767650076528,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C105-114","TSGH-C108-141","TSGH-E-109238"],"award-info":[{"award-number":["TSGH-C105-114","TSGH-C108-141","TSGH-E-109238"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST106-2314-B-016-026-MY3"],"award-info":[{"award-number":["MOST106-2314-B-016-026-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jmii.2021.05.001","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T06:48:13Z","timestamp":1624517293000},"page":"926-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Growth arrest-specific 6 protein in HIV-infected patients: Determination of plasma level and different antiretroviral regimens"],"prefix":"10.1016","volume":"54","author":[{"given":"Te-Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Huang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chun","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Hsing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-2116","authenticated-orcid":false,"given":"Ning-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2021.05.001_bib1","doi-asserted-by":"crossref","first-page":"7886","DOI":"10.1128\/JVI.02612-09","article-title":"Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hst from pathogenic SIV infection of rhesus macaques","volume":"84","author":"Harris","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jmii.2021.05.001_bib2","doi-asserted-by":"crossref","first-page":"19851","DOI":"10.1073\/pnas.0810032105","article-title":"HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells","volume":"105","author":"Catalfamo","year":"2008","journal-title":"Proc Nati Acad Sci U S A"},{"key":"10.1016\/j.jmii.2021.05.001_bib3","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/infdis\/jiq138","article-title":"A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response","volume":"203","author":"Hatano","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/QAD.0b013e3282f560d9","article-title":"Association of antiretroviral therapy with fibrinogen levels in HIV-infection","volume":"22","author":"Madden","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2021.05.001_bib6","first-page":"1735","article-title":"Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death","volume":"27","author":"Boulware","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib7","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/infdis\/jir507","article-title":"Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells","volume":"204","author":"Lederman","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/cyto.a.20643","article-title":"Phenotype and function of human T lymphocyte subsets: consensus and issues","volume":"73","author":"Appay","year":"2008","journal-title":"Cytometry"},{"key":"10.1016\/j.jmii.2021.05.001_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jmii.2021.05.001_bib10","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"EI-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2021.05.001_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.qai.0000437171.00504.41","article-title":"Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202","volume":"65","author":"McComsey","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jmii.2021.05.001_bib12","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1182\/blood-2007-05-089565","article-title":"Gas 6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes","volume":"111","author":"Tjwa","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2021.05.001_bib13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/01.ATV.0000160611.68791.c6","article-title":"Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice","volume":"25","author":"Maquoi","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jmii.2021.05.001_bib14","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-09-528752","article-title":"TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis","volume":"123","author":"Van der Meer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2021.05.001_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-230X(08)00002-X","article-title":"TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer","volume":"100","author":"Linger","year":"2008","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.jmii.2021.05.001_bib16","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.2337\/dc09-1073","article-title":"Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction","volume":"33","author":"Hung","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jmii.2021.05.001_bib17","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/jit453","article-title":"Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial","volume":"208","author":"Hatano","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/15321810801888480","article-title":"Development and validation of an ELISA method for detection of growth arrest specific 6 (GAS6) protein in human plasma","volume":"29","author":"Alciato","year":"2008","journal-title":"J Immunoassay Immunochem"},{"key":"10.1016\/j.jmii.2021.05.001_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11904-012-0118-8","article-title":"HIV and inflammation: mechanisms and consequences","volume":"9","author":"Hunt","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jmii.2021.05.001_bib20","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.1061663","article-title":"Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family","volume":"293","author":"Lu","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jmii.2021.05.001_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0952-7915(02)00016-X","article-title":"Macrophage regulation by Tyro 3 family receptors","volume":"15","author":"Lemke","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jmii.2021.05.001_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jmii.2021.05.001_bib24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1586\/1744666X.2013.842897","article-title":"Immunodiscordant responses to HAART mechanisms and consequences","volume":"9","author":"Massanella","year":"2013","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.jmii.2021.05.001_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/ciw409","article-title":"Inflammatory biomarkers and mortality risk among HIV-suppressed men: a multisite prospective cohort study","volume":"63","author":"Wada","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib26","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/605890","article-title":"Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells","volume":"200","author":"French","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib27","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(08)60423-7","article-title":"Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration","volume":"371","author":"Sabin","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2021.05.001_bib28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/infdis\/jir509","article-title":"Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy","volume":"204","author":"Satchell","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib29","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/QAD.0b013e32832e7140","article-title":"Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients","volume":"23","author":"Hsue","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2021.05.001_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cid\/cir269","article-title":"Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era","volume":"53","author":"Bedimo","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/ciq244","article-title":"No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001\/ALLRT","volume":"52","author":"Ribaudo","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1570162X1401151102143222","article-title":"Changes in serum markers of inflammation and endothelial activation in HIV-infected antiretroviral na\u00efve patietns starting a treatment with Abacavir-Lamivudine or Tenovovir-Emtricitabine plus Efavirenze","volume":"14","author":"Calza","year":"2016","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.jmii.2021.05.001_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3851\/IMP2681","article-title":"Comparison of cardiovascular disease risk markers in HIVinfected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study","volume":"19","author":"Wohl","year":"2014","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jmii.2021.05.001_bib34","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1097\/QAD.0b013e32833f147f","article-title":"Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial","volume":"24","author":"Martin","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2021.05.001_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2334-14-122","article-title":"Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study","volume":"14","author":"Hattab","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2334-13-203","article-title":"Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and heptic function in HIV patients receiving protease inhibitors","volume":"13","author":"Cassol","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2021.05.001_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114142","article-title":"Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals","volume":"9","author":"Massanella","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jmii.2021.05.001_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.gastro.2009.08.054","article-title":"HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells","volume":"138","author":"Wu","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmii.2021.05.001_bib39","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/QAD.0b013e328359f29c","article-title":"Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir","volume":"26","author":"Mart\u00ednez","year":"2012","journal-title":"AIDS"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118221000979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118221000979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:27:03Z","timestamp":1761658023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118221000979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1684118221000979"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2021.05.001","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth arrest-specific 6 protein in HIV-infected patients: Determination of plasma level and different antiretroviral regimens","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2021.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}